Digital innovation and proactive patient care are converging to transform clinical practice while preserving essential safeguards.
|Articles|June 24, 2008
FDA expands the indication for Velcade for multiple myeloma patients.
FDA expands the indication for Velcade for multiple myeloma patients.
Advertisement
Since 2003, multiple myeloma patients who have relapsed and who have had at least one prior therapy have been able to take Velcade (bortezomib, Millennium Pharmaceuticals, The Takeda Oncology Co., and Takeda Pharmaceutical Co.) to increase their survival. Now the Food & Drug Administration has granted the injection a new indication-for use among previously untreated patients with multiple myeloma. The
To see more Daily News articles,
To go to the Drug Topics homepage,
Advertisement
Related to this article
James Barnes, CPhT, explains why respecting a patient's time isn't about speed and how he landed in the pharmacy by chance.
ACIP changes, new court rulings, and coverage gaps threaten vaccines, pharmacists’ reimbursement, and children's access through Vaccine For Children.
As pouched products increase in popularity, researchers assess their pharmacology, harm-reduction potential, and initiation risk.
The approval is the first new treatment advance in more than 30 years for chronic kidney disease for adults with type 1 diabetes.
Adults with serious mental illness receive GLP-1 prescriptions at rates similar to or higher than their peers, though schizophrenia continued to lag.
Madeline Sutton, MD, MPH, FACOG, joins to discuss risks of HPV infection among women and how pharmacists can improve outcomes in this area.
In part 2, Vanessa Slowey explains the pharmacy industry’s need for due diligence as technology reinforces patient convenience in the 21st century.
Advertisement
Advertisement
Trending on Drug Topics
1
GLP-1 Prescribing Rose Among Adults With Serious Mental Illness
2
Scripted for Her: The Pharmacist's Role in HPV Prevention
3
AI, Automation Are Transforming Pharmacies into Proactive Care Hubs
4
FDA Approves Finerenone for Chronic Kidney Disease With Type 1 Diabetes
5